Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of ...

Daiichi Sankyo Co. Ltd.’s trophoblast cell surface antigen 2 (Trop2)-directed antibody-drug conjugate (ADC), datopotamab ...

Driven by declining competitiveness, the new European Commission will start 2025 by getting to work on an EU-wide industrial ...

Novel vaccines that can effectively target both coronaviruses and influenza viruses would be desirable to counteract the ...

From local drug discovery to global innovation, economic uncertainty is taking a toll on China’s innovative biotech system, ...

Ausperbio Therapeutics Inc. raised $110 million from two financing rounds in 2024 to advance its lead antisense ...

In a deal worth up to $1 billion, Ideaya Biosciences Inc. is in-licensing Jiangsu Hengrui Pharmaceuticals Co. Ltd.’s SHR-4849 ...

Among the most profound results presented at the 2024 European Society for Medical Oncology Congress were the 10-year data ...

Azole derivatives have been used as antifungal drugs in clinical practice for many years. However, limitations such as ...

Around the end of every year, the media reports on pregnancy and women who give birth on the last and first days of the new ...

Hoth Therapeutics Inc. has entered into an exclusive patent license agreement with the U.S. Department of Veterans Affairs ...

Prostatic-specific antigen (PSA) is commonly used as a screening tool for prostate cancer but presents limited sensitivity ...